ArticleProceedings of the National Academy of Sciences of the United States of America2016

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

Shiri Weinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.